vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Industrial Logistics Properties Trust (ILPT). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $113.9M, roughly 1.5× Industrial Logistics Properties Trust). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 3.1%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 0.7%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.
ESPR vs ILPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $113.9M |
| Net Profit | — | $-1.8M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | -22.1% |
| Net Margin | — | -1.6% |
| Revenue YoY | 143.7% | 3.1% |
| Net Profit YoY | — | 92.6% |
| EPS (diluted) | $0.32 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $113.9M | ||
| Q3 25 | $87.3M | $110.9M | ||
| Q2 25 | $82.4M | $112.1M | ||
| Q1 25 | $65.0M | $111.9M | ||
| Q4 24 | $69.1M | $110.5M | ||
| Q3 24 | $51.6M | $108.9M | ||
| Q2 24 | $73.8M | $110.6M | ||
| Q1 24 | $137.7M | $112.2M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | $-31.3M | $-21.6M | ||
| Q2 25 | $-12.7M | $-21.3M | ||
| Q1 25 | $-40.5M | $-21.5M | ||
| Q4 24 | — | $-24.1M | ||
| Q3 24 | $-29.5M | $-25.0M | ||
| Q2 24 | $-61.9M | $-23.2M | ||
| Q1 24 | $61.0M | $-23.4M |
| Q4 25 | 50.6% | -22.1% | ||
| Q3 25 | -11.4% | -29.4% | ||
| Q2 25 | 8.6% | -30.8% | ||
| Q1 25 | -34.0% | -26.9% | ||
| Q4 24 | -6.4% | -31.1% | ||
| Q3 24 | -31.0% | -33.5% | ||
| Q2 24 | 3.5% | -32.4% | ||
| Q1 24 | 52.5% | -31.7% |
| Q4 25 | — | -1.6% | ||
| Q3 25 | -35.9% | -19.4% | ||
| Q2 25 | -15.4% | -19.0% | ||
| Q1 25 | -62.2% | -19.2% | ||
| Q4 24 | — | -21.8% | ||
| Q3 24 | -57.2% | -22.9% | ||
| Q2 24 | -83.9% | -20.9% | ||
| Q1 24 | 44.3% | -20.9% |
| Q4 25 | $0.32 | $-0.02 | ||
| Q3 25 | $-0.16 | $-0.33 | ||
| Q2 25 | $-0.06 | $-0.32 | ||
| Q1 25 | $-0.21 | $-0.33 | ||
| Q4 24 | $-0.14 | $-0.37 | ||
| Q3 24 | $-0.15 | $-0.38 | ||
| Q2 24 | $-0.33 | $-0.35 | ||
| Q1 24 | $0.34 | $-0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $94.8M |
| Total DebtLower is stronger | — | $4.2B |
| Stockholders' EquityBook value | $-302.0M | $489.7M |
| Total Assets | $465.9M | $5.2B |
| Debt / EquityLower = less leverage | — | 8.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $94.8M | ||
| Q3 25 | $92.4M | $83.2M | ||
| Q2 25 | $86.1M | $58.6M | ||
| Q1 25 | $114.6M | $108.0M | ||
| Q4 24 | $144.8M | $131.7M | ||
| Q3 24 | $144.7M | $153.9M | ||
| Q2 24 | $189.3M | $146.2M | ||
| Q1 24 | $226.6M | $128.4M |
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | $4.2B | ||
| Q2 25 | — | $4.2B | ||
| Q1 25 | — | $4.3B | ||
| Q4 24 | — | $4.3B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.3B | ||
| Q1 24 | — | $4.3B |
| Q4 25 | $-302.0M | $489.7M | ||
| Q3 25 | $-451.4M | $494.1M | ||
| Q2 25 | $-433.5M | $519.1M | ||
| Q1 25 | $-426.2M | $539.5M | ||
| Q4 24 | $-388.7M | $562.0M | ||
| Q3 24 | $-370.2M | $585.9M | ||
| Q2 24 | $-344.2M | $618.3M | ||
| Q1 24 | $-294.3M | $643.2M |
| Q4 25 | $465.9M | $5.2B | ||
| Q3 25 | $364.0M | $5.2B | ||
| Q2 25 | $347.1M | $5.2B | ||
| Q1 25 | $324.0M | $5.4B | ||
| Q4 24 | $343.8M | $5.4B | ||
| Q3 24 | $314.1M | $5.5B | ||
| Q2 24 | $352.3M | $5.5B | ||
| Q1 24 | $373.1M | $5.5B |
| Q4 25 | — | 8.56× | ||
| Q3 25 | — | 8.49× | ||
| Q2 25 | — | 8.09× | ||
| Q1 25 | — | 7.96× | ||
| Q4 24 | — | 7.65× | ||
| Q3 24 | — | 7.35× | ||
| Q2 24 | — | 6.96× | ||
| Q1 24 | — | 6.70× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $60.7M |
| Free Cash FlowOCF − Capex | — | $42.0M |
| FCF MarginFCF / Revenue | — | 36.9% |
| Capex IntensityCapex / Revenue | 0.0% | 16.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $79.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $60.7M | ||
| Q3 25 | $-4.3M | $22.7M | ||
| Q2 25 | $-31.4M | $18.4M | ||
| Q1 25 | $-22.6M | $11.4M | ||
| Q4 24 | $-35.0M | $2.0M | ||
| Q3 24 | $-35.3M | $-3.4M | ||
| Q2 24 | $-7.2M | $10.8M | ||
| Q1 24 | $53.8M | $8.0M |
| Q4 25 | — | $42.0M | ||
| Q3 25 | — | $17.6M | ||
| Q2 25 | — | $15.2M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | — | $-3.7M | ||
| Q3 24 | $-35.5M | $-5.9M | ||
| Q2 24 | $-7.3M | $9.4M | ||
| Q1 24 | $53.8M | $5.9M |
| Q4 25 | — | 36.9% | ||
| Q3 25 | — | 15.9% | ||
| Q2 25 | — | 13.5% | ||
| Q1 25 | — | 4.5% | ||
| Q4 24 | — | -3.4% | ||
| Q3 24 | -68.7% | -5.5% | ||
| Q2 24 | -9.9% | 8.5% | ||
| Q1 24 | 39.0% | 5.2% |
| Q4 25 | 0.0% | 16.4% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 0.0% | 2.9% | ||
| Q1 25 | 0.0% | 5.7% | ||
| Q4 24 | 0.0% | 5.2% | ||
| Q3 24 | 0.3% | 2.3% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.1% | 1.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
ILPT
Segment breakdown not available.
